PLUS THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
PLUS THERAPEUTICS, INC. has filed 1,439 SEC EDGAR filings since 30 Mar 2001

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
4

FORM 4

Filing date
15 Apr 2014
Reporting date
11 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Apr 2014
Reporting date
11 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Apr 2014
Reporting date
11 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Apr 2014
Reporting date
11 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K

Filing date
02 Apr 2014
Reporting date
02 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34375

CYTORI THERAPEUTICS, INC 10-K 12-31-2013

Filing date
14 Mar 2014
Reporting date
31 Dec 2013
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K

Filing date
11 Mar 2014
Reporting date
11 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-80327

SC 13D

Filing date
28 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-34375

CT ORDER filing

Filing date
20 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-192409

EFFECT filing

Filing date
13 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-34375

10-Q/A

Filing date
12 Feb 2014
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-192409

FORM S-3/A

Filing date
11 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Feb 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS, INC 8-K 1-30-2014

Filing date
04 Feb 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80327

SC 13G/A filing

Filing date
28 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2014
Reporting date
10 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2014
Reporting date
01 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2014
Reporting date
01 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2014
Reporting date
01 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2014
Reporting date
01 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2014
Reporting date
01 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-192409

FORM S-3

Filing date
19 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .